Comparative safety of mRNA COVID-19 vaccines to influenza vaccines: A pharmacovigilance analysis using WHO international database

Two messenger RNA (mRNA) vaccines developed by Pfizer-BioNTech and Moderna are being rolled out. Despite the high volume of emerging evidence regarding adverse events (AEs) associated with the COVID-19 mRNA vaccines, previous studies have thus far been largely based on the comparison between vaccina...

Full description

Bibliographic Details
Main Authors: Ahn, J.G (Author), Barnett, Y. (Author), Butler, L. (Author), Clemens, J.D (Author), Dragioti, E. (Author), Eisenhut, M. (Author), Excler, J.-L (Author), Hong, S.H (Author), Il Shin, J. (Author), Ilie, C.P (Author), Jacob, L. (Author), Jung, S.Y (Author), Kim, H. (Author), Kim, J.H (Author), Kim, M.S (Author), Koyanagi, A. (Author), Kronbichler, A. (Author), Lee, S.W (Author), Marks, F. (Author), Ogino, S. (Author), Park, S.J (Author), Salem, J.-E (Author), Shin, E.-C (Author), Shoenfeld, Y. (Author), Smith, L. (Author), Tizaoui, K. (Author), Yon, D.K (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2022
Subjects:
Online Access:View Fulltext in Publisher